These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9470138)

  • 1. Treatment of behavioural disturbances in Parkinson's disease.
    Valldeoriola F; Nobbe FA; Tolosa E
    J Neural Transm Suppl; 1997; 51():175-204. PubMed ID: 9470138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Parkinson's disease. Psychological disorders: striking a balance in order to optimise antiparkinsonian treatment.
    Prescrire Int; 2011 Oct; 20(120):242-5. PubMed ID: 21970092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical management of levodopa-associated motor complications in patients with Parkinson's disease.
    Jankovic J; Stacy M
    CNS Drugs; 2007; 21(8):677-92. PubMed ID: 17630819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuropsychiatric disorders in Parkinson's disease].
    Noé-Sebastián E; Irimia-Sieira P; Pomares-Arias E; Martínez-Vila E; Luquin-Piudo MR
    Rev Neurol; 2001 Apr 1-15; 32(7):676-81. PubMed ID: 11391498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences].
    Drach LM
    Med Monatsschr Pharm; 2011 Feb; 34(2):47-52; quiz 53-4. PubMed ID: 21428015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment options for depression and psychosis in Parkinson's disease.
    Poewe W; Seppi K
    J Neurol; 2001 Sep; 248 Suppl 3():III12-21. PubMed ID: 11697683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease.
    Barone P; Amboni M; Vitale C; Bonavita V
    Neurology; 2004 Oct; 63(8 Suppl 3):S35-8. PubMed ID: 15505142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.
    Friedman JH; Factor SA
    Mov Disord; 2000 Mar; 15(2):201-11. PubMed ID: 10752567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.
    Lhommée E; Klinger H; Thobois S; Schmitt E; Ardouin C; Bichon A; Kistner A; Fraix V; Xie J; Aya Kombo M; Chabardès S; Seigneuret E; Benabid AL; Mertens P; Polo G; Carnicella S; Quesada JL; Bosson JL; Broussolle E; Pollak P; Krack P
    Brain; 2012 May; 135(Pt 5):1463-77. PubMed ID: 22508959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced psychotic symptoms in Parkinson's disease. Problems, management and dilemma.
    Kuzuhara S
    J Neurol; 2001 Sep; 248 Suppl 3():III28-31. PubMed ID: 11697685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of selegiline (deprenyl) in the treatment of Parkinson's disease.
    Heinonen EH; Myllylä V
    Drug Saf; 1998 Jul; 19(1):11-22. PubMed ID: 9673855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatric aspects of Parkinson's disease--an update.
    Schrag A
    J Neurol; 2004 Jul; 251(7):795-804. PubMed ID: 15258780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychiatric complications of Parkinson's disease: their symptoms and treatment].
    Castro-García A; Sesar-Ignacio A; Ares-Pensado B
    Rev Neurol; 2004 Oct 1-15; 39(7):646-50. PubMed ID: 15490352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of mental disorders in patients with Parkinson's disease].
    Meincke U; Kosinski CM
    Fortschr Neurol Psychiatr; 2010 May; 78(5):279-87. PubMed ID: 20422492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When a Parkinson's disease patient starts to hallucinate.
    Poewe W
    Pract Neurol; 2008 Aug; 8(4):238-41. PubMed ID: 18644910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
    Prescrire Int; 2002 Feb; 11(57):1-6. PubMed ID: 11985366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of psychotic aspects of Parkinson's disease.
    Juncos JL
    J Clin Psychiatry; 1999; 60 Suppl 8():42-53. PubMed ID: 10335670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current management of motor fluctuations in patients with advanced Parkinson's disease treated chronically with levodopa.
    Melamed E; Zoldan J; Galili-Mosberg R; Ziv I; Djaldetti R
    J Neural Transm Suppl; 1999; 56():173-83. PubMed ID: 10370911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric syndromes in Parkinson's disease.
    Starkstein SE; Brockman S; Hayhow BD
    Curr Opin Psychiatry; 2012 Nov; 25(6):468-72. PubMed ID: 22992542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sleep disturbances in Parkinson's disease].
    Boczarska-Jedynak M; Opala G
    Neurol Neurochir Pol; 2005; 39(5):380-8. PubMed ID: 16273462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.